Welcome to EURACTIV's health Brief, your weekly update on health policy in the EU from EURACTIV's health news team: Gerardo Fortuna, Giedre Peseckyte and Clara Bauer.
…
continue reading
Can bacteria communicate with each other, and if they do communicate, how and why do they do so? And how might understanding the mechanisms of bacterial communication be used to inform development of anti-bacterial drugs? In this album scientists involved in pioneering work into bacterial 'quorum sensing'' at Nottingham University in the UK reveal some of the techniques they use and give insight into what they hope to achieve. This material forms part of The Open University course S204 Biolo ...
…
continue reading
The State of Health is the podcast where patients put healthcare decision makers, thought leaders, and policy makers in the hot seat.Hosted by Gunnar Esiason, a patient advocate living with cystic fibrosis, The State of Health gives listeners a front row seat to patient advocacy. Gunnar's three decades of surviving inside the American healthcare system has given him a front row seat to the complexities that make health care delivery so challenging. The State of Health will unravel these comp ...
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Medscape Medical Minute
George D. Lundberg, MD, Editor-in-Chief, The Medscape Journal of Medicine; Adjunct Professor of Heal
In The Medscape Medical Minute, Dr. George Lundberg, Editor-in-Chief of The Medscape Journal of Medicine and eMedicine.com, offers clinicians a brief synopsis and commentary of key evidence-based clinical studies from the medical literature.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Understanding vaccine hesitancy in Europe
12:20
12:20
Play later
Play later
Lists
Like
Liked
12:20
This week EURACTIV's health reporter Marta Iraola talks to Dr. Emilie Karafillakis about vaccine confidence in Europe and what is behind people's lack of trust in vaccination and public health campaigns. In this episode, the health team reunites before the summer to say goodbye to this podcast as from September health topics will be covered under B…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
AI: at the Interface of computer science and Medicine
32:33
32:33
Play later
Play later
Lists
Like
Liked
32:33
From YouTube-recommended videos to facial recognition used to unlock smartphones, AI is already being used on a daily basis. The healthcare sector is not an exception as its ability to process vast amounts of medical data helps in diagnostics and medical image analysis. To better understand where AI is already used and what potential it holds, EURA…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
European Health Data Space on the Parliament's Plate
25:54
25:54
Play later
Play later
Lists
Like
Liked
25:54
As the European Parliament debates how European health data space should be shaped, EURACTIV talks with the co-rapporteur of the file, Croatian MEP Tomislav Sokol (EPP), touching on primary and secondary use of data, the reasons why parliament supports the opt-out option and what is left to discuss before the discussions can start with the Council.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Balancing patients' privacy and health data's potential
20:29
20:29
Play later
Play later
Lists
Like
Liked
20:29
European Health Data Space (EHDS) focuses on the primary and secondary use of data. While the primary use of data is data used by citizens and healthcare professionals at the national and EU levels the secondary data is to be used by researchers, policy makers and pharma. The Commission's proposal does not include any say for patients regarding the…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The challenge of guaranteeing access to healthcare to all Ukrainian refugees
19:08
19:08
Play later
Play later
Lists
Like
Liked
19:08
On the occasion of the first Healthcare Forum, which took place in Wąsowo, Poland last week, Euractiv spoke with the Regional Director of WHO/Europe, Dr Hans Kluge. In this interview, Dr. Kluge looked back on his meeting with the Polish and Ukrainian Ministers of Health about the Healthy Reconstruction of Ukraine. He dug into the physical and menta…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
A closer look at Europe's fertility challenge
10:39
10:39
Play later
Play later
Lists
Like
Liked
10:39
This week EURACTIV'S health team explores why fertility is decreasing across the globe, what challenges people face when they want children and the situation of fertility treatments in Europe. For that, Health Reporter Marta Iraola talks with Dr Carlos Calhaz-Jorge, a specialist in obstetrics and gynaecology and chair of the European Society for Hu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Endocrine Disrupting Chemicals: a silent threat for children's development
14:07
14:07
Play later
Play later
Lists
Like
Liked
14:07
This week, EURACTIV’s health team dives into how endocrine-disrupting chemicals (EDC) can affect children, especially in their most important developmental years. They talk with Doctor Anders Juul, a paediatric endocrinologist at Rigshospitalet in Copenhagen. He explains how children are exposed to these chemicals and the health issues this can cau…
…
continue reading
Psilocybin, MDMA or LSD might associate with party drugs but their therapeutic value is being discovered worldwide. Ian Roullier took part in two clinical trials that looked at the effects of psilocybin on depression. Through his personal experience, Roullier shares his insights on psychedelic-assisted therapy, its potential value to patients and w…
…
continue reading
Tobacco is responsible for 8 million deaths a year but despite that governments across the world spend millions supporting tobacco farms, according to WHO Director-General Tedros Ghebreyesus. As 31 May marks World No Tobacco Day, EURACTIV’s health team talks with Rudiger Krech, WHO Director of the Health Promotion Department, on the impact of toxic…
…
continue reading
From psychedelics and mental health literature to having pets in EU institutions - EURACTIV’s health reporter Giedrė Peseckytė is talking with three MEPs - Maria Walsh from Christian Democrats, Mikuláš Peksa from the Greens and Karen Melchior from Renew - about mental health.By Euractiv
…
continue reading
As this week is European Testing Week, a European campaign that aims to increase testing efforts and promote awareness of the benefits of earlier hepatitis and HIV testing, EURACTIV's health team is talking with Jens Lundgren, Professor of infectious diseases at the University of Copenhagen in Denmark. He has been involved with clinical HIV researc…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Discovering Monderna's new landscape for vaccines in Europe
11:26
11:26
Play later
Play later
Lists
Like
Liked
11:26
This week, EURACTIV’s health team talks with Chantal Friebertshäuser, Senior Vice President at Moderna for Europe, the Middle East and Canada. They discuss the end of COVID and the new vaccine they are developing against cancer. They also talk about the new facility the biotechnology company recently opened in Madrid, Spain. This new laboratory, eq…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Unwrapping the new pharmaceutical legislation
13:51
13:51
Play later
Play later
Lists
Like
Liked
13:51
This week, EURACTIV’s health team dives into the proposal for a new pharmaceutical legislation and the complicated way ahead. For that, they talk with stakeholders working on health policy at the EU level about their priorities and main concerns.By Euractiv
…
continue reading
This week, EURACTIV’s health team dives into endocrine disruptors and the effect these chemicals can have on our hormonal system. They talk with Doctor Angel Nadal, professor of physiology at the University Miguel Hernandez in Spain, about the current framework and what else can be done at the EU level.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Fact checking The Whale’s obesity portrayal
12:08
12:08
Play later
Play later
Lists
Like
Liked
12:08
This week, EURACTIV’s journalist Marta Iraola talks about the movie ‘The Whale’ with Jacqueline Bowman-Busato, head of policy at the European Association for the Study of Obesity. They focus on the controversies about its portrayal of obesity and the reception among the patient community.By Euractiv
…
continue reading
This week, EURACTIV’s journalist Giedrė Peseckytė is talking with a Polish pro-abortion activist Justyna Wydrzynska who got sentenced in mid-March to eight months of community service for sharing abortion pills with another woman back in 2020. *The interview was conducted on 23 March.By Euractiv
…
continue reading
Marking world Tuberculosis day (24 March) we are talking with two Ukrainians about how Ukrainians are fighting not only Russia's invasion but also one of the highest incidences of TB cases in the European region.By Euractiv
…
continue reading
This week, EURACTIV’s health team explores the outstanding revision of the EU framework on substances of human origins (SoHo) together with Annemette Arndal-Lauritzen, CEO of the European Sperm Bank, with a focus on the revision of the EU rules for sperm donation.By Euractiv
…
continue reading
This week, EURACTIV's health journalists Marta Iraola and Gerardo Fortuna dig into the troubled implementation of the new framework for medical devices in Europe which entered into force in 2021. When developers of medical devices started experiencing problems in meeting the deadlines for implementing the key rules of the new regulation, the EU law…
…
continue reading
This week, EURACTIV’s journalists Clara Bauer and Gerardo Fortuna sat with the EU’s health Commissioner Stella Kyriakides to talk about women’s health on the occasion of International Women’s Day. The EU health chief also gave some anticipations on what is coming up next in the EU’s health policy agenda.…
…
continue reading
This week, EURACTIV’s health team brings you the nitty-gritty of the European Health Data Space together with one of the European Parliament's rapporteur on the file, the centre-right Croatian MEP Tomislav SokolBy Euractiv
…
continue reading
This week, EURACTIV's health team dig into the European Parliament’s role in the ongoing saga on the transparency of the COVID-19 vaccine contracts between the European Commission and the pharmaceutical company Pfizer with MEP Tilly Metz.By Euractiv
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 22: Pharmacy Benefit Managers (PBMs) and Their Hidden Role in Drug Pricing
40:06
40:06
Play later
Play later
Lists
Like
Liked
40:06
Today on the show we take a look at the shadow world where pharmacy benefit managers or PBM’s operate to influence drug prices. Joining us is Antonio Ciaccia, the CEO of 46Brooklyn Research, an Ohio non-profit corporation whose purpose is to improve the accessibility and usability of U.S. drug pricing data. PBMs are a meaningful part of the US drug…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 21: Antibiotic Resistance: How CARB-X Helps New Companies Get a Running Start
31:30
31:30
Play later
Play later
Lists
Like
Liked
31:30
Kevin Outterson, the Executive Director of Boston-based CARB-X, a global non-profit partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria, joins the podcast to talk with Gunnar about the early-stage landscape for biotechnology companies developing novel antibiotics. Unlike the AMR…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 20: Antibiotic Resistance: Bacteriophages, a Possible Answer?
30:49
30:49
Play later
Play later
Lists
Like
Liked
30:49
The antibiotic resistance series on the State of Health has discussed, at length, the policy and market dysfunctions at the heart of the antibiotic crisis. This week, Gunnar talks with Dr. Ben Chan, an Associate Research Scientist in the department of Ecology and Evolutionary Biology at Yale University, and Ella Balasa, a cystic fibrosis patient ad…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 19: Antibiotic Resistance: PASTEUR Act with Senator Michael Bennet
17:38
17:38
Play later
Play later
Lists
Like
Liked
17:38
Senator Michael Bennet, a co-sponsor of the bipartisan PASTEUR Act, joins Gunnar on the State of Health to talk about his proposed legislation to correct the dysfunctional antibiotic market. Senator Bennet makes his pitch for why he believes people should care about antibiotic resistance, talks about how the PASTEUR Act can become law, and shares h…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 18: Antibiotic Resistance: Investing in the Next Generation of Antibiotics
42:43
42:43
Play later
Play later
Lists
Like
Liked
42:43
The State of Health continues the Antibiotic Resistance series with an episode featuring Henry Skinner, the CEO of the AMR Action Fund, a novel kind of investment fund that aims to catalyze the innovation ecosystem for novel antibiotics. Gunnar and Henry talk about the challenges of bringing new antibiotics to market, the difference between the AMR…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 17: Antibiotic Resistance: PASTEUR Act with Senator Todd Young
15:25
15:25
Play later
Play later
Lists
Like
Liked
15:25
Senator Todd Young from Indiana joins the podcast to talk about the PASTEUR Act, a bipartisan piece of legislation that he is co-sponsoring with Senator Michael Bennet that aims to reform the way novel antibiotics are paid for in the United States. Unlike most prescription drugs, antibiotics are unique in that they lose their efficacy over time tha…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 16: Antibiotic Resistance: The Patient Experience
41:31
41:31
Play later
Play later
Lists
Like
Liked
41:31
The State of Health is back after a brief summer vacation. This week, Emma D'Agostino, PhD joins the show to talk with Gunnar about their jointly written opinion piece that appeared in The Hill in mid-August entitled: New bipartisan legislation can encourage needed antibiotic development, where they called for bipartisan reform of the antibiotic ma…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 15: Immunocompromised Transplant Patients Return to Vaccine Clinics for Booster Shots
26:56
26:56
Play later
Play later
Lists
Like
Liked
26:56
Katy Monte, an immunocompromised woman who has received three transplants as a result of her end-stage cystic fibrosis, talks to Gunnar about getting a third COVID-19 vaccine after the FDA recommended booster shots for people who may not have developed antibodies after the initial doses. She explains the conversations she had with her care teams, h…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 14: Huntington's Disease and Patient Advocacy with Seth Rotberg
35:00
35:00
Play later
Play later
Lists
Like
Liked
35:00
Seth Rotberg joins the podcast to talk through the in's and out's of patient advocacy, the patient's role in drug development, and how patients can work with regulators to make sure the best possible medications reach approval. Since Gunnar considers himself a patient advocate, too, they are able to talk about their frustrations with the role, but …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 13: Three Questions with Utah Governor Spencer Cox
21:56
21:56
Play later
Play later
Lists
Like
Liked
21:56
In the end of summer 2020, Gunnar sat down to talk with then Lieutenant Governor Spencer Cox about the policymaker's connection with cystic fibrosis and the state's evolving response to COVID-19. Gunnar also solicits a question from a Utahan living with cystic fibrosis for the then Lieutenant Governor to answer. Gunnar talks about the need for soci…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 12: The Future of the Drug Industry
26:52
26:52
Play later
Play later
Lists
Like
Liked
26:52
Dr. Bill Smith, a visiting fellow in the life sciences at the Boston-based think tank, Pioneer Institute, and former drug industry veteran, joins the State of Health to talk about the evolving market dynamics in the drug industry starting with the Orphan Drug Act and the industry's rush into therapeutic development for rare diseases. In this episod…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 11: Three Questions with Governor Mike Dunleavy (Alaska)
20:07
20:07
Play later
Play later
Lists
Like
Liked
20:07
In this Three Questions episode where the role of the interviewer flips halfway through the show, Gunnar and Alaska Governor, Mike Dunleavy, talk about Alaska's early success with the state's vaccination campaign, the state's integrated health system and how Alaska's reliance on telehealth could be a playbook for other states as they look to normal…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 10: Drug Access in Canada with Chris MacLeod
40:54
40:54
Play later
Play later
Lists
Like
Liked
40:54
Chris MacLeod is a Canadian living with cystic fibrosis and practicing attorney, who has been a fierce advocate for patients who need access to life-sustaining medications or treatments. He founded the not-for-profit organization Canadian Cystic Fibrosis Treatment Society to assist in carrying out this work. He also recently released a book entitle…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 9: Turning Hope into Action with Dr. David Fajgenbaum and the Castleman Disease Collaborative Network
26:24
26:24
Play later
Play later
Lists
Like
Liked
26:24
Dr. David Fajgenbaum joins Gunnar on the podcast to talk about his New York Times Bestselling book, "Chasing My Cure: A Doctor’s Race to Turn Hope Into Action" and his journey from division 1 college football quarterback and medical student to a rare disease patient up against the clock to find a treatment for his suddenly diagnosed Castleman Disea…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 8: Drug Pricing, Valuing Innovation and No Patient Left Behind with Peter Kolchinsky
53:17
53:17
Play later
Play later
Lists
Like
Liked
53:17
Biotechnology investor, Peter Kolchinsky, joins the State of Health to talk with Gunnar about drug pricing. The conversation covers the long term view that when drugs go generic without undue delay, the value they provide to society is far greater than the short-run value that cost effectiveness analyses often show, which Peter details in his book,…
…
continue reading
Liz Salmi, a self-described "former punk rock drummer turned cancer patient, and now senior research strategist," joins the show to paint a successful case study of joint-patient, physician, and researcher advocacy. She tells the story about the data-driven and evidence-based case for "open progress notes" and the impact they can have on patient ca…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 6: Ask Patients! Jen Horonjeff and the Savvy Co-op
28:25
28:25
Play later
Play later
Lists
Like
Liked
28:25
Patient engagement is more than a buzzword for career and lifelong patients. The lived experience of chronic disease holds tangible value that is often exploited under the guise of altruism. What if patients could capture some of the value generated by the healthcare delivery system and industry? The State of Health welcomes one entrepreneur who is…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 5: Three Questions with Bob Coughlin from MassBio
25:57
25:57
Play later
Play later
Lists
Like
Liked
25:57
Gunnar Esiason and Bob Coughlin, the former CEO of MassBio, talk about the state of the biotechnology industry in the background of the COVID-19 pandemic. Bob shares why the biotechnology trade association is important for biotech companies in Massachusetts, before getting into the industry's reputation and how he thinks the pandemic will impact th…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 4: Carmela Coyle and the California Hospital Association
33:49
33:49
Play later
Play later
Lists
Like
Liked
33:49
Carmela Coyle, the President and CEO of the California Hospital Association joins Gunnar to talk about the state of hospitals in California. In this deep dive interview, Gunnar wants to how how the hospitals of tomorrow will be shaped by today's pandemic and if the hospital industry sees telehealth as a competitor in care delivery. Gunnar challenge…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 3: Three Questions with Governor Mike Parson (MO)
22:00
22:00
Play later
Play later
Lists
Like
Liked
22:00
Governor Mike Parson from Missouri joined Gunnar Esiason for a three questions chat where they talked health policy and rare diseases in Missouri. Gunnar shares a personal connection to St. Louis University School of Medicine, and then asks the Governor how the state is managing care for people with rare and complex diseases while hospitals stress …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 2: Lindsey Leininger, Dear Pandemic, and The Fight Against Misinformation
49:14
49:14
Play later
Play later
Lists
Like
Liked
49:14
Lindsey Leininger, the nerdy-Girl-in-Chief, at Dear Pandemic, a website where bona fide nerdy girls post real info on COVID-19, joins the show to talk about the state of the pandemic, lessons learned, how data should be used to inform public policy and how she fights back against misinformation. She is a public health scientist who teaches and writ…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 1: Three Questions with Governor Phil Murphy (NJ)
19:50
19:50
Play later
Play later
Lists
Like
Liked
19:50
Gunnar and New Jersey Governor Phil Murphy do a three questions style interview where the role of the interviewer flips halfway through the show. Governor Murphy talks about the state of the healthcare industry in New Jersey, how the COVID-19 pandemic will reshape health policy choices in the state, and why the pandemic's shift to remote work could…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Trailer: The State of Health with Gunnar Esiason
3:14
3:14
Play later
Play later
Lists
Like
Liked
3:14
Welcome to the State of Health, patients put healthcare decision makers and thought leaders in the hot seat. Join Gunnar Esiason, a cystic fibrosis patient advocate and rare disease patient leader, as he rolls back the curtain on the healthcare system through conversations with political leaders, industry decision makers, thought leaders and, of co…
…
continue reading
A short introduction to this album.By The Open University
…
continue reading
With antibiotic resistant bacteria constantly emerging, scientists are trying to find new types of anti bacterial drugs. One promising area of research is bacterial communication.By The Open University
…
continue reading
Quorum sensing is the process by which bacteria seem to communicate with each other and make decisions to behave en masse. The game of Risk as an analogue for the battles that go on within the body between pathogens and the body's defencesBy The Open University
…
continue reading
Exploring the possiblility of developing new types of antibiotics interfere with the communication between bacteria, rather than killing the invading pathogens.By The Open University
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Skin-to-Skin Contact Provides Analgesia to Neonates
1:17
1:17
Play later
Play later
Lists
Like
Liked
1:17
Skin-to-Skin Contact Provides Analgesia to NeonatesBy George D. Lundberg, MD, Editor-in-Chief, The Medscape Journal of Medicine; Adjunct Professor of Heal
…
continue reading